PT1056467E - Processo para o tratamento de doencas ou perturbacoes do ouvido interno - Google Patents

Processo para o tratamento de doencas ou perturbacoes do ouvido interno

Info

Publication number
PT1056467E
PT1056467E PT99910259T PT99910259T PT1056467E PT 1056467 E PT1056467 E PT 1056467E PT 99910259 T PT99910259 T PT 99910259T PT 99910259 T PT99910259 T PT 99910259T PT 1056467 E PT1056467 E PT 1056467E
Authority
PT
Portugal
Prior art keywords
inner ear
sensory cells
diseases
treatment
cells
Prior art date
Application number
PT99910259T
Other languages
English (en)
Portuguese (pt)
Inventor
Hubert Loewenheim
Original Assignee
Sound Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sound Pharmaceuticals Inc filed Critical Sound Pharmaceuticals Inc
Publication of PT1056467E publication Critical patent/PT1056467E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT99910259T 1998-02-23 1999-02-23 Processo para o tratamento de doencas ou perturbacoes do ouvido interno PT1056467E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807426A DE19807426A1 (de) 1998-02-23 1998-02-23 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs

Publications (1)

Publication Number Publication Date
PT1056467E true PT1056467E (pt) 2004-02-27

Family

ID=7858563

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99910259T PT1056467E (pt) 1998-02-23 1999-02-23 Processo para o tratamento de doencas ou perturbacoes do ouvido interno

Country Status (11)

Country Link
US (1) US7087581B1 (enExample)
EP (1) EP1056467B1 (enExample)
JP (1) JP2002503687A (enExample)
AT (1) ATE250936T1 (enExample)
AU (1) AU763868B2 (enExample)
CA (1) CA2320717C (enExample)
DE (2) DE19807426A1 (enExample)
DK (1) DK1056467T3 (enExample)
ES (1) ES2211055T3 (enExample)
PT (1) PT1056467E (enExample)
WO (1) WO1999042088A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530817A (ja) 1999-06-01 2003-10-21 ベイラー カレッジ オブ メディスン 聴覚障害、変形性関節症および細胞の異常増殖に関するatonal関連配列の治療用途のための組成物および方法
DE10027777A1 (de) * 2000-06-07 2001-12-13 Otogene Ag Transfektionsverfahren
EP1307542A2 (en) * 2000-07-11 2003-05-07 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
EP1547618B1 (en) 2002-10-02 2010-05-26 AnGes MG, Inc. Drug for auditory dysfunction
US20060148829A1 (en) * 2002-12-17 2006-07-06 Laurent Meijer Means for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti
EP2293800B1 (en) 2008-06-06 2016-10-05 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
DE102010007281A1 (de) 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
RU2480195C1 (ru) * 2011-11-02 2013-04-27 Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава РФ") Способ лечения заболеваний внутреннего уха
EP2802657B1 (en) 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
WO2013134022A1 (en) * 2012-03-05 2013-09-12 Wake Forest University Health Sciences Regeneration of inner ear cells
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
EP0866716A4 (en) * 1995-11-13 2002-05-02 Cambridge Neuroscience Inc METHOD FOR TREATING DISORDERS OF THE NON-VISUAL SENSORIC EPITHEL
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor
AU3591597A (en) 1996-06-28 1998-01-21 Regents Of The University Of California, The Transformation and genetherapy of cells of the inner ear
AU4600297A (en) * 1996-09-27 1998-04-17 Trustees Of The University Of Pennsylvania, The Novel methods for inducing proliferation in auditory receptor epithelium
US6043221A (en) 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product

Also Published As

Publication number Publication date
DE19807426A1 (de) 1999-10-14
DK1056467T3 (da) 2004-02-09
DE59907195D1 (de) 2003-11-06
EP1056467A2 (de) 2000-12-06
AU2928199A (en) 1999-09-06
CA2320717A1 (en) 1999-08-26
WO1999042088A2 (de) 1999-08-26
EP1056467B1 (de) 2003-10-01
ES2211055T3 (es) 2004-07-01
CA2320717C (en) 2009-03-24
JP2002503687A (ja) 2002-02-05
AU763868B2 (en) 2003-07-31
WO1999042088A3 (de) 2000-03-02
ATE250936T1 (de) 2003-10-15
US7087581B1 (en) 2006-08-08

Similar Documents

Publication Publication Date Title
PA8478501A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
DE50010931D1 (de) Substituierte benzimidazole
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
DK0738270T3 (da) Dihydropyrazolopyrroler
PT1056467E (pt) Processo para o tratamento de doencas ou perturbacoes do ouvido interno
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
AP9901479A0 (en) Heterocyclic compounds as inhibitors of rotamase enzymes.
ATE311371T1 (de) Nicht-peptide inhibitoren von vla-4 abhängiger zellbindung für die behandlung von entzündungen, autoimmune krankheiten und atemstörungen
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DE60008753D1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
SE9902267D0 (sv) New compounds
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
NO982863L (no) Nye forbindelser med analgetisk effekt
HK1048439A1 (zh) 用於治疗视神经及视网膜损伤之腺激酶抑制剂
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
HK1042090A1 (zh) N-取代的具有5-羟色胺能活性的酰亚胺衍生物
RU2008124830A (ru) Производное рапамицина или ингибитор impdh для лечения поликистозного заболевания почек
MY141048A (en) Morpholine derivatives as norepinephrine reuptake inhibitors
ATE361079T1 (de) Verwendung von pyrimidinnukleotiden zur behandlung von schaedigungen des peripheren nervensystems
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
DE69807586D1 (de) Verwendung eines Alkylendioxybenzolderivats zur Behandlung von zirkadianen Schlafstörungen